| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/26/2007 | US7235571 Insecticides; for human or veterinary medicine |
| 06/26/2007 | US7235569 5-HT1A receptor antagonists and serotonin uptake inhibitors; increasing levels of serotonin in synapse and reducing latency period; psychological disorders |
| 06/26/2007 | US7235568 N-dihydrobenzofuran-7-yloxyethyl-substituted, e.g., [2-(2,2-Dimethyl-2,3-dihydrobenzofuran-7-yl-oxy)ethyl]-(5-cyclopenten-1-ylpyridin-3-ylmethyl)amine; benzofuran ring may 2-spirocyclopropyl- or 2-spirocyclobutyl-substituted |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235560 Pyrimidine derivative as selective COX-2 inhibitors |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 06/26/2007 | CA2413037C Intermediates for producing antitumor indolopyrrolocarbazole derivatives |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2155014C Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative |
| 06/21/2007 | WO2007069771A1 Benzoylpyrazole compounds and herbicides containing them |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069569A1 Organic electroluminescence element material and organic electroluminescence element using same |
| 06/21/2007 | WO2007069050A2 Processes for the preparation of alfuzosin |
| 06/21/2007 | WO2007068905A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS |
| 06/21/2007 | WO2007068814A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof |
| 06/21/2007 | WO2007068739A1 4-amino-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, neurological and cardiovascular disorders |
| 06/21/2007 | WO2007048841A3 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 06/21/2007 | WO2007048064A3 Amino-pyrimidines as casein kinase ii (ck2) modulators |
| 06/21/2007 | WO2007003604A3 Hists1mine h3 receptor antagonists |
| 06/21/2007 | WO2006124861A3 Benzofuran compounds |
| 06/21/2007 | US20070142631 Enzyme inhibiton immunoassay |
| 06/21/2007 | US20070142449 Angiogenesis inhibitors |
| 06/21/2007 | US20070142448 such as 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxyl]-N,N,2-trimethyl-1H-benzimidazole -6-carboxamide, used as acid pump antagonists for the treatment of gastrointestinal disorders |
| 06/21/2007 | US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia |
| 06/21/2007 | US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142391 Piperazine-2-carboxamide derivatives |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 06/21/2007 | US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives |
| 06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
| 06/21/2007 | US20070142372 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/21/2007 | US20070142371 Anti-Cytokine Heterocyclic Compounds |
| 06/21/2007 | US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer |
| 06/21/2007 | US20070142310 treating Human Immuno-Deficiency Virus (HIV); nucleoside or nucleotide analogues; RNA viral diseases; anticarcinogenic agents treating hematopoetic cancers |
| 06/21/2007 | US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R) |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
| 06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
| 06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | CA2632437A1 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumours |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798229A1 Substituted biphenyl derivative |
| 06/20/2007 | EP1797087A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 06/20/2007 | EP1797078A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 06/20/2007 | EP1797077A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 06/20/2007 | EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/20/2007 | EP1797075A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| 06/20/2007 | EP1797074A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 06/20/2007 | EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 06/20/2007 | EP1797067A1 New heterocyclic amides |
| 06/20/2007 | EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| 06/20/2007 | EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 06/20/2007 | EP1797045A1 Novel pyrimidine derivatives and their use as ppar-alpha modulators |
| 06/20/2007 | EP1797040A1 Muscarinic receptor antagonists |
| 06/20/2007 | EP1797035A2 Cyclopropyl piperidine glycine transporter inhibitors |
| 06/20/2007 | EP1796793A2 Novel compounds |
| 06/20/2007 | EP1611094B1 Pyrazole compounds |
| 06/20/2007 | EP1610786B1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP0890119B1 Photochromic naphthopyran compositions of neutral color |
| 06/20/2007 | CN1984905A Constrained himbacine analogs as thrombin receptor antagonists |
| 06/20/2007 | CN1984904A 3-aryl-5,6-disubstituted pyridazines |
| 06/20/2007 | CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. |
| 06/20/2007 | CN1984900A Indole derivatives having piperidine rings |
| 06/20/2007 | CN1984897A Light-emitting device material and light-emitting device |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984885A Bicyclic aromatic sulfinyl derivatives |
| 06/20/2007 | CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1982307A Process for synthesizing chiral N-aryl piperazines |
| 06/20/2007 | CN1322001C Novel compounds that inhibit factor Xa activity |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232905 Reacting an aldehyde, a beta -keto ester and urea or thiourea in the presence of a polyaniline salt catalyst and separating the substituted dihydropyrimidinone obtained thereby |
| 06/19/2007 | US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists |
| 06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 06/19/2007 | US7232818 Compounds for enzyme inhibition |
| 06/19/2007 | US7232812 Substituted azetidine compounds, their preparation and use as medicaments |
| 06/19/2007 | CA2304624C Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent |
| 06/14/2007 | WO2007067629A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | WO2007067444A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |